ethyl 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylate

ID: ALA1098059

PubChem CID: 44232942

Max Phase: Preclinical

Molecular Formula: C19H19N5O2

Molecular Weight: 349.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2

Standard InChI:  InChI=1S/C19H19N5O2/c1-3-26-18(25)16-14-10-9-12-11-20-19(21-13-7-5-4-6-8-13)22-15(12)17(14)24(2)23-16/h4-8,11H,3,9-10H2,1-2H3,(H,20,21,22)

Standard InChI Key:  XCLOVJZYWDYYRT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   16.7304   -7.3748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7293   -8.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4436   -8.6143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4418   -6.9623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1568   -7.3712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1602   -8.1992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5876   -7.3653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8682   -6.9519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5910   -8.1933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8739   -8.6091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0479   -9.4197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8725   -9.5047    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2080   -8.7468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9169   -8.3284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6348   -8.7339    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.9090   -7.5040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0149   -8.6133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3011   -8.2006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3022   -7.3762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5893   -6.9634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8739   -7.3752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8759   -8.2040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5894   -8.6129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6307  -10.1315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6427   -9.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3607   -9.9637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
  3  6  2  0
 13 14  1  0
  1  2  2  0
 14 15  1  0
  5  8  1  0
 14 16  2  0
  6 10  1  0
  2 17  1  0
  9  7  1  0
 17 18  1  0
  7  8  1  0
 18 19  2  0
  9 10  2  0
 19 20  1  0
  5  4  2  0
 20 21  2  0
  4  1  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
 11 24  1  0
  2  3  1  0
 15 25  1  0
 10 11  1  0
 25 26  1  0
M  END

Associated Targets(Human)

CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin CDK4/Cyclin D3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND3 Tchem CDK6/cyclin D3 (897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 349.39Molecular Weight (Monoisotopic): 349.1539AlogP: 2.90#Rotatable Bonds: 4
Polar Surface Area: 81.93Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.74CX Basic pKa: 1.71CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -1.17

References

1. Beria I, Ballinari D, Bertrand JA, Borghi D, Bossi RT, Brasca MG, Cappella P, Caruso M, Ceccarelli W, Ciavolella A, Cristiani C, Croci V, De Ponti A, Fachin G, Ferguson RD, Lansen J, Moll JK, Pesenti E, Posteri H, Perego R, Rocchetti M, Storici P, Volpi D, Valsasina B..  (2010)  Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.,  53  (9): [PMID:20397705] [10.1021/jm901713n]
2. Zhao H, Hu X, Cao K, Zhang Y, Zhao K, Tang C, Feng B..  (2018)  Synthesis and SAR of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as potent and selective CDK4/6 inhibitors.,  157  [PMID:30165341] [10.1016/j.ejmech.2018.08.043]

Source